Cramer Rosenthal McGlynn
Mutual Funds

CRM All Cap Value

Assets Under Management: $23 million as of June 30, 2024

Ticker Inception CUSIP Net Expense Ratio1 Gross Expense Ratio Current Assets Minimum Investment
Institutional CRIEX October 24, 2006 12626X833 1.19% 1.19% $17 million $1,000,000
Investor CRMEX October 24, 2006 12626X841 1.42% 1.42% $7 million $2,500

¹The net expense ratio for the CRM All Cap Value Fund is the ratio listed in the CRM Funds Prospectus, dated October 27, 2023.


CRM All Cap Value Fund seeks long-term capital appreciation. The CRM All Cap Value Fund, under normal circumstances, invests at least 80% of its assets in a diversified portfolio of equity and equity related securities of U.S. and non-U.S. companies that are publicly traded on a U.S. securities market. There are no limits on the market capitalizations of companies in which the All Cap Value Fund may invest.

Supported by an experienced team of investment professionals, the portfolio managers make judgments about the relative attractiveness of various securities in selecting stocks for the portfolio. All stocks held in the other products are not held in the All Cap Value Fund, and it falls upon the portfolio managers to decide which holdings are the most attractive in this portfolio. This strategy will typically be invested in 35 to 50 stocks. Although the Fund is built from the bottom up, stock specific risks, sector weightings and risk/reward characteristics are all taken into account in the portfolio construction process.

Top Ten Equity Holdings

As of March 31, 2024

It should not be assumed that the holdings presented have been profitable or will in the future be profitable. Holdings are subject to change at any time without notice.

Fidelity National Information Services, Inc.3.8%
Marathon Oil Corporation3.6%
Kirby Corporation3.5%
Terreno Realty Corporation3.0%
ChampionX Corporation3.0%
Advanced Drainage Systems, Inc.3.0%
Charles Schwab Corporation2.9%
Sun Communities, Inc.2.9%
Clarivate PLC2.7%
Burlington Stores, Inc.2.7%

Most Recent Funds Distribution-2023

As a shareholder of a Fund, you are entitled to dividends and other distributions arising from net investment income and net realized gains, if any, earned on the investments held by the Funds. Dividends and distributions, if any, are declared and paid annually to you. Each Fund expects to distribute any net realized gains once a year.

Distributions are payable to the shareholders of record at the time the distributions are declared (including holders of shares being redeemed, but excluding holders of shares being purchased). All distributions are reinvested in additional Fund shares unless you have elected to receive the distributions in cash.

CRM All Cap Value Fund

  • Date of Record: December 6, 2023
  • Ex-Date: December 7, 2023
  • Payment Date: December 8, 2023
Short Term Long Term Ordinary Income Total
Institutional Class $0.0528 $0.0654 $0.0257 $0.1439
Investor Class $0.0528 $0.0654 $0.0079 $0.1261


As of June 30, 2024


Annualized Returns (%)

YearAll Cap ValueRussell 3000 Value IndexRussell 3000 Index
1 Yr13.7712.9323.13
3 Yr2.575.148.05
5 Yr8.518.8914.14
10 Yr7.648.1012.15


Annualized Returns (%)

YearAll Cap ValueRussell 3000 Value IndexRussell 3000 Index
1 Yr13.4712.9323.13
3 Yr2.305.148.05
5 Yr8.238.8914.14
10 Yr7.378.1012.15

The performance above represent past performance, which does not guarantee future results. If you invest in a Fund, your investment return and principal value will fluctuate, so that your shares, when redeemed, may be worth more of less than their original cost. The Fund’s current performance may be lower or higher than the performance above. For most recent month-end performance, please click here.

Shares of CRM Funds are distributed by ALPS Distributors, Inc.

Cramer Rosenthal McGlynn, LLC is the investment advisor to the CRM Funds and is not affiliated with ALPS.

You should consider the investment objectives, risks, charges and expenses of the Funds carefully before investing. Before making an investment, please download a prospectus containing all the information about the Funds or call 800.276.2883. You should read the prospectus carefully before investing.